An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia

Summary

The purpose of this study is to evaluate the efficacy, tolerability and safety of paliperidone extended release (ER) tablets (between 3 to 12 milligram (mg), once a day) in the prevention of relapse in schizophrenia participants.

Timeline

Start

2011-06

Primary completion

2013-04

Completion

2013-04

Drugs

Indications